 |
|
|
 |
|
Antidepressants May Fight Colorectal Cancer
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 Until carefully controlled studies are done, "treatment of colorectal cancer should not be changed," he said.
Collet said: "The next step should be to study the effects of SSRIs in high-risk populations, such as persons with a family history of colorectal cancer, to see whether in this treatment we can find protection. Also, studies might be done in patients who have cancer, to see whether after surgery, we could reduce the rate of recurrence or metastasis [spread of cancer elsewhere in the body]."
Future studies would have to take into account such factors as diet, use of other drugs and the presence of diseases such as diabetes and inflammatory bowel disease, which can affect the risk of colorectal cancer, the researchers wrote.
Text Continues Below

If studies do confirm the cancer-fighting effects of SSRIs, that could boost sales of the already-popular drugs. About 100 million SSRI prescriptions are written each year in the United States, and the number of prescriptions in Canada rose from 3.2 million in 1981 to 14.5 million in 2000, the report said.
More information
The U.S. National Institutes of Health (history.nih.gov ) can tell you more about SSRI antidepressants.
Page: << Prev | 1 | 2
|
Copyright © 2006 ScoutNews LLC. All rights reserved.
Last updated 3/27/2006
| | | MyBreastCancerNetwork.com - Information on breast cancer: signs and symptoms, breast health, and breast cancer drugs and treatments. Join a community of breast cancer support and stories. | | | BipolarConnect.com - Information on bipolar disorder: signs and symptoms, mental health, risks, treatments and other information on bipolar disorder. | | | MyDepressionConnection.com - Learn about the types of depression and their signs, depression in teens, children, and elderly, treating depression, and depression drugs. Get depression help from blogs and depression support forums. |
|
 |

SOURCES: Jean-Paul Collet, M.D., professor of biostatistics and epidemiology, McGill University, Montreal, Canada; Henrik Toft Sorensen, M.D., professor of clinical epidemiology, Aarhus University, Denmark; April 2006, Lancet Oncology
|